Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis

Journal of Rheumatology

Volumn 25, Issue 2, 1998, Pages 243-246

  Rahman, Proton ^a   Humphrey Murto, Susan ^a   Gladman, Dafna D ^a,b   Urowitz, Murray B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Arthritis; Methotrexate; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG RESISTANCE; DRUG TOLERABILITY; FEMALE; HUMAN; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; ANTIMALARIALS; ARTHRITIS; COHORT STUDIES; FEMALE; FOLIC ACID; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHOTREXATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031934953     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gladman DD, Urowitz MB. Systemic lupus erythematosus: Clinical features. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby, 1994:2:6:2.1-2.20.
2. Davidson JR, Graziano FM, Rothenberg RJ. Methotrexate therapy for severe systemic lupus erythematosus [letter]. Arthritis Rheum 1987;30:1195-6.
3. Rothenberg RJ, Graziano FM, Grandote JT, et al. The use of methotrexate in steroid resistant systemic lupus erythematosus. Arthritis Rheum 1988;31:612-5.
4. Wilke WS, Krall PL, Sheetz RJ, et al. Methotrexate for systemic lupus erythematosus: A retrospective analysis of 17 unselected cases. Clin Exp Rheumatol 1991;9:581-7.
5. Wilson K, Abeles M. A two year open ended trial of methotrexate in systemic lupus erythematosus. J Rheumatol 1994;21:1674-7.
6. Walz Le Blanc BAE, Dagenais P, Urowitz MB, Gladman DD. Methotrexate in systemic lupus erythematosus. J Rheumatol 1994;21:836-8.
7. Ferraccioli GF, De Vita S, Bartoli E. Methotrexate benefits in patients with lupus with and without nephritis [letter]. J Rheumatol 1995;22:1442.
8. Arfi S, Numeric T, Groilier L, et al. Traitement du lupus erythematous systemique corticodependant par le methotrexate a faibles doses [Treatment of corticosteroid dependent systemic lupus erythematosus with low dose methotrexate]. Rev Med Intern 1995;16:885-90.
9. Guil Garcia M, Garcia Portales R, Fernandez Nebro A, et al. Effectiveness of treatment of systemic lupus erythematosus with methotrexate. Medicina Clinica 1993;110:361-4.
10. Asherson RA, Schatten S, Hughes GRV. Methotrexate in systemic lupus erythematosus. J Rheumatol 1997;24:610-1.
11. Wise CM, Vuyyuru S, Roberts WN. Methotrexate in nonrenal lupus and undifferentiated connective tissue disease - A review of 36 patients. J Rheumatol 1996;23:1005-10.
12. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
14. Williams HJ, Wilkens RF, Samuelson COJ, et al. Comparison of low dose pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1985;28:721-30.
15. Thompson RN, Watts C, Edelman J, Esdaile J, Russell AS. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol 1984;11:760-3.
16. Anderson PA, West SG, O'Dell JR, et al. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunological effects in a randomized, double blind study. Ann Intern Med 1985;103:489-96.
17. Tugwell P, Bennett K, Gent M. Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy and safety. Ann Intern Med 1987;107:358-66.
18. Fox DA, McCune WJ. Immunosuppressive drug therapy of systemic lupus erythematosus. Rheum Dis Clin North Am 1994;20:265-99.
19. Kipen Y, Littlejohn GO, Morand EF. Methotrexate use in systemic lupus erythematosus. Lupus 1997;6:385-9.